Articles
Subscribe
Articles
Newsletter
Jobs Board
Femtech Investors
About
Contact
Search for:
Copyright © 2026 Fitt. All rights reserved.
Privacy Policy
.
Terms and Conditions
.
Pharma
All Categories
5-Minute-Briefs
Accelerator
Access
Acquisition
Announcement
Ask Me Anything
Autoimmune
Awards
Biotech
Bone Health
Brain Health And Cognitive Health
Breast Health
Breastfeeding
Cancer
Career
China
Chronic Conditions
Competition
Consumer Goods
Consumer Health
Corporate Innovation
Crowdfunding
Cycle Care
Digital Health
Dtc
Ecosystem
Endometriosis
Events
Exit
Famtech
Featured Funder
Femtech Tv
Fertility
Gut Health
Gynecological Health
Health
Health Equity
Healthcare
Heart Disease
Hormonal Health
How To
Infant Health
Inner Circle
Insights
Interview
Investment
Investment Round-ups
Investor
Jobs
Longevity
Maternal Health
Medical Device
Menopause
Mens Health
Menstruation
Mental Health
Metabolic Health
Microbiome
Motherhood
News
Newsletter
Oncology
Opinion
Partner
Partnership
Pelvic Health
Period Care
Pharma
Podcast
Policy
Pregnancy
Press Release
Products
Regulatory
Reports
Reproductive Health
Research
Sextech
Sexual Wellness
Sponsored Post
Sports
Spotlight
Starter Story
Startup
Sustainability
Trend Watch
Uncategorized
Vaginal Infections
Wearable
Womens Health
Search for:
August 20, 2026
Bird&Be Partners With Mandell’s Clinical Pharmacy to Expand Fertility Care Access
July 15, 2026
FDA Approves Celcuity’s REVTORPYK for HR+/HER2-, PIK3CA Wild-Type Advanced Breast Cancer
July 15, 2026
Veradermics Reports Positive Phase 2 Results for Oral Non-Hormonal Hair Loss Drug in Women
July 13, 2026
Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals
July 7, 2026
Organon Licenses Hormone-Free Copper IUD MIUDELLA for Global Commercialization
May 26, 2026
FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years
May 19, 2026
FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
April 28, 2026
Sun Pharma to Acquire Women’s Health Pharma Giant Organon in $11.75 Billion Deal
April 9, 2026
European Biopharma Investor Jeito Capital Closes $1.2B Fund
April 1, 2026
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment
March 30, 2026
Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment
March 25, 2026
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis
March 20, 2026
Novartis Acquires Next-Generation Breast Cancer Drug in $3 Billion Deal
March 3, 2026
Gedeon Richter Acquires Celmatix’s Women’s Health Drug Discovery Portfolio
February 18, 2026
Teijin Pharma and Aska Pharmaceutical Partner to Discover New Small-Molecule Drugs for Gynecological Diseases
February 18, 2026
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment
February 13, 2026
FDA Approves Merck’s Keytruda for Platinum-Resistant Ovarian Cancer
January 21, 2026
FDA Approves Five-Year Duration of Use for Organon’s Nexplanon Contraceptive Implant
December 17, 2025
ADEL Signs $1.04 Billion Licensing Deal with Sanofi for Alzheimer’s Antibody Therapy
December 11, 2025
Daré Bioscience Opens Pre-Orders for Topical Sildenafil Cream for Female Arousal
December 10, 2025
Roche Launches Bacterial Vaginosis and Candida Vaginitis Diagnosis Test Following CE Mark Approval
November 26, 2025
FDA Approves First Pertuzumab Biosimilar for HER2-Positive Breast Cancer Treatment
November 21, 2025
Roche’s Giredestrant Shows Positive Phase III Results in Early Breast Cancer Trial
November 11, 2025
FDA Removes Black Box Warnings from Menopausal HRT Products
1
2
3
…
6